tiprankstipranks
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market

Autolus Therapeutics (AUTL) Income Statement

Compare
632 Followers

Autolus Therapeutics Income Statement

Last quarter (Q3 2024), Autolus Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Autolus Therapeutics's net income was $-82.09M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.70M$ 6.19M$ 2.33M$ 242.00K$ 2.91M
Gross Profit
$ -4.87M$ -131.03M$ -126.32M$ -134.65M$ -1.70M
Operating Expenses
$ 1.70M$ 173.72M$ 166.65M$ 168.39M$ 144.87M
Depreciation and Amortization
$ 6.57M$ 7.42M$ 8.55M$ 5.75M$ 4.61M
EBITDA
$ -156.77M$ -135.54M$ -132.01M$ -160.51M$ -134.40M
Operating Income
$ -195.03M$ -163.78M$ -164.21M$ -168.15M$ -137.86M
Other Income/Expenses
$ -13.37M$ -9.42M$ 109.22M$ 1.89M$ 2.95M
Pretax Income
$ -208.40M$ -173.21M$ -165.99M$ -166.26M$ -139.01M
Net Income
$ -208.38M$ -148.84M$ -142.10M$ -142.09M$ -123.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.20$ -1.57$ -1.97$ -2.76$ -2.88
Diluted EPS
$ -1.20$ -1.57$ -1.97$ -2.76$ -2.88
Weighted Average Shares Outstanding
173.94M 94.99M 72.08M 51.56M 43.07M
Weighted Average Shares Outstanding (Diluted)
173.94M 94.99M 72.08M 51.56M 43.07M
Currency in USD

Autolus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis